High-dose idarubicin plus busulfan as conditioning regimen to autologous stem cell transplantation: Promising post-remission therapy for acute myeloid leukemia in first complete remission?
Crossref DOI link: https://doi.org/10.1007/s12032-014-0980-x
Published Online: 2014-05-07
Published Print: 2014-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hong, Ming
Miao, Kou-Rong
Zhang, Run
Lu, Hua
Liu, Peng
Xu, Wei
Chen, Li-Juan
Zhang, Su-Jiang
Wu, Han-Xin
Qiu, Hong-Xia
Li, Jian-Yong
Qian, Si-Xuan
Text and Data Mining valid from 2014-05-07